Metronomic scheduling of trofosfamide chemotherapy in human NSCLC xenografts highly increases therapeutic efficacy compared to conventional scheduling by inhibition of angiogenesis.

S. Stölting; T. Klink; C. Bela; C. Engels; T. Wagner

doi:10.5414/CPP42652

Metronomic scheduling of trofosfamide chemotherapy in human NSCLC xenografts highly increases therapeutic efficacy compared to conventional scheduling by inhibition of angiogenesis.

S. Stölting^*, T. Klink, C. Bela, C. Engels, T. Wagner

^*Korrespondierende/r Autor/-in für diese Arbeit

Universitätsklinikum Hamburg-Eppendorf

8 Zitate (Scopus)

Originalsprache	Englisch
Zeitschrift	International journal of clinical pharmacology and therapeutics
Jahrgang	42
Ausgabenummer	11
Seiten (von - bis)	652-653
Seitenumfang	2
ISSN	0946-1965
DOIs	https://doi.org/10.5414/CPP42652
Publikationsstatus	Veröffentlicht - 01.01.2004

UN SDGs

Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung

Dokumente

10.5414/CPP42652

Weitere Links

Link to publication in Scopus

Zitieren

@article{220212fc30444b8ca89d4a1b1bbaf906,

title = "Metronomic scheduling of trofosfamide chemotherapy in human NSCLC xenografts highly increases therapeutic efficacy compared to conventional scheduling by inhibition of angiogenesis.",

author = "S. St{\"o}lting and T. Klink and C. Bela and C. Engels and T. Wagner",

year = "2004",

month = jan,

day = "1",

doi = "10.5414/CPP42652",

language = "English",

volume = "42",

pages = "652--653",

journal = "International journal of clinical pharmacology and therapeutics",

issn = "0946-1965",

number = "11",

}

Stölting, S, Klink, T, Bela, C, Engels, C & Wagner, T 2004, 'Metronomic scheduling of trofosfamide chemotherapy in human NSCLC xenografts highly increases therapeutic efficacy compared to conventional scheduling by inhibition of angiogenesis.', International journal of clinical pharmacology and therapeutics, Jg. 42, Nr. 11, S. 652-653. https://doi.org/10.5414/CPP42652

Metronomic scheduling of trofosfamide chemotherapy in human NSCLC xenografts highly increases therapeutic efficacy compared to conventional scheduling by inhibition of angiogenesis. / Stölting, S.; Klink, T.; Bela, C. et al.
in: International journal of clinical pharmacology and therapeutics, Jahrgang 42, Nr. 11, 01.01.2004, S. 652-653.

Publikation: Beiträge in Fachzeitschriften › Zeitschriftenaufsätze › Forschung › Begutachtung

TY - JOUR

T1 - Metronomic scheduling of trofosfamide chemotherapy in human NSCLC xenografts highly increases therapeutic efficacy compared to conventional scheduling by inhibition of angiogenesis.

AU - Stölting, S.

AU - Klink, T.

AU - Bela, C.

AU - Engels, C.

AU - Wagner, T.

PY - 2004/1/1

Y1 - 2004/1/1

UR - http://www.scopus.com/inward/record.url?scp=16644393421&partnerID=8YFLogxK

U2 - 10.5414/CPP42652

DO - 10.5414/CPP42652

M3 - Journal articles

C2 - 15598036

AN - SCOPUS:16644393421

SN - 0946-1965

VL - 42

SP - 652

EP - 653

JO - International journal of clinical pharmacology and therapeutics

JF - International journal of clinical pharmacology and therapeutics

IS - 11

ER -